Tables and Figures
1. Global Asthma Network
Figure. Global Asthma Network Centres at June 2018
Table. Aspirations of the Global Asthma Network
2. What is Asthma?
Table: Asthma Symptoms and components
3. Global Burden of Disease due to Asthma
Figure 1. Prevalence of asthma symptoms among 13-14 year olds (ISAAC).
Figure 2. Prevalence of severe asthma among 13-14 year olds (ISAAC).
Prevalence of symptoms of asthma in the last 12 months among persons aged 18 to 45, 70 countries, World Health Survey 2002-2003.
Figure 4. Burden of disease, measured by disability adjusted life years (DALYs) per 100,000 population attributed to asthma by age group and sex, 2010.
4. Hospital Admissions for Asthma
Figure 1. Age-standardised admission rates for asthma (all ages) in 30 European countries, 2001-2005 and 2011-2015, ranked by age-standardised admission rate in 2011-2015.
Figure 2. Relative changes in age-standardised rates of hospitalisation for asthma, 2011-2015 vs. 2001-2005, for adults (age 20+) and children & adolescents (age 0-19) in 25 European countries.
Figure 3. Schematic representation of long-term time trends in self-reported asthma prevalence, hospital admission rates and mortality rates for asthma among children in high-income countries (some European countries, USA, Canada, Australia, New Zealand, Hong Kong and Singapore).
Figure 4. Annual change in hospital admission rates for childhood asthma (ages 5-14) in countries with one or more ISAAC centres providing prevalence data for both ISAAC Phase One (1993-5) and ISAAC Phase Three (2001-3), by change in prevalence of nocturnal wheezing among 13-14-year-olds.
5. Asthma Mortality
Figure 1. Age-standardised asthma mortality rates for all ages, 2001-2005 and 2011-2015, by country, ordered by mortality rate and income group.
Figure 2. Age-standardised asthma mortality rates for ages 5-34 years only, 2001-2005 and 2011-2015, by country, ordered by mortality rate and income group.
Figure 3. Relative changes in age-standardised mortality and hospitalisation rates for asthma (all ages) in 24 European countries, 2011-2015 vs 2001-2005.
6. The Economic Burden of Asthma
Figure. Success of a national asthma strategy: overall annual costs of asthma care at the societal level in Finland from 1987 to 2013; the national asthma program began in 1994. Monetary values are in euros (€).
7. Factors Affecting AsthmaFigure. Effects of individual-level exposures on wheeze in the last 12 months Mixed logistic regression models with random intercepts at the school, centre and country levels.
8. Cost-effectiveness of Asthma Management using Inhaled Corticosteroids
9. Spacers for Asthma and Wheezing in Children
10. Achieving Access to Affordable, Quality-Assured, Essential Asthma Medicines
Table. Measures needed to improve access to affordable quality-assured essential asthma medicines.
11. Asthma Management in Low-Income Countries
Table. Standard case management: The eight components.
Figure. Example of financial mechanism to maintain supply and reduce cost.
12. Asthma in regions: Country reports from Africa
Figure: Cover page of the Guideline for Asthma Management in Nigeria.
Table. Prevalence of current symptoms of asthma (12 month prevalence rate of wheeze) by centre in South Africa in 6 – 7 year and 13 – 14 year age groups as measured on the International Study of Asthma and Allergies in Childhood (ISAAC) Phases 1 and 3."/>
Africa-tailored spirometry training course:
13. Asthma in regions: Country reports from Asia and India
Figure: Prevalence of asthma (asthma symptoms in the past 2 years) in children under 14 years from 43 major cities across China in 2010.
Table. Epidemiology studies on childhood asthma in Indonesia (2008-17).
14. Asthma in regions: Country reports from Latin America
Figure. Trends in asthma mortality in Argentina (1980-2015)Age- and sex-adjusted rates, crude rate and number of deaths.
16. Asthma as an NCD PriorityTable. Actions required to ensure asthma becomes a global priority
17. Asthma and the UN’s Sustainable Development Goals 2030
Tables and Figures in Appendices
Table. Prevalence of current symptoms of asthma by world region in 6 – 7 year and 13 – 14 year age groups as measured in the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three.